25754 Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

An agenda and any additional 

information for the meeting will be 

posted on the agency’s Web site: 

http://www.nih.gov/about/director/acd/ 

index.htm. 

Background information may be 

obtained by contacting NIH OBA by email oba@od.nih.gov 

Dated: April 29, 2008. 

Amy P. Patterson, 

Director, Office of Biotechnology Activities. 

[FR Doc. E8–10011 Filed 5–6–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

F—Manpower & Training; NCI–F Manpower 

and Training Grants. 

Date: May 19, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Old Town Alexandria, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Lynn M. Amende, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8105, 

Bethesda, MD 20892, 301–451–4759, 

amendel@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 30, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–10013 Filed 5–6–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Advisory Board. 

Open: June 17, 2008, 8:30 a.m. to 3:20 p.m. 

Agenda: Program reports and 

presentations; Business of the Board. 

Place: National Cancer Institute, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Closed: June 17, 2008, 3:20 p.m. to 5 p.m. 

Agenda: Review of grant applications. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Open: June 18, 2008, 8:30 a.m. to 12 p.m. 

Agenda: Program reports and 

presentations; Business of the Board. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page http:// 

deainfo.nci.nih.gov/advisory/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 30, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–10014 Filed 5–6–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Toxicology Program (NTP); 

Office of Liaison, Policy and Review; 

Meeting of the Scientific Advisory 

Committee on Alternative 

Toxicological Methods (SACATM) 

AGENCY: National Institute of 

Environmental Health Sciences 

(NIEHS), National Institutes of Health 

(NIH). 

ACTION: *COM057*Meeting 

announcement and request for 

comment. 

SUMMARY: Pursuant to section 10(a) of 

the Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of 

SACATM on June 18–19, 2008, at the 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices 25755 

Radisson Hotel Research Triangle Park, 

150 Park Drive, Research Triangle Park, 

NC 27709. The meeting is scheduled 

from 8:30 a.m. to 5:30 p.m. on June 18 

and 8:30 a.m. until adjournment on June 

19. The meeting is open to the public 

with attendance limited only by the 

space available. SACATM advises the 

Interagency Coordinating Committee on 

the Validation of Alternative Methods 

(ICCVAM), the NTP Interagency Center 

for the Evaluation of Alternative 

Toxicological Methods (NICEATM), and 

the Director of the NIEHS and NTP 

regarding statutorily mandated duties of 

ICCVAM and activities of NICEATM. 

DATES: The SACATM meeting will be 

held on June 18 and 19, 2008. All 

individuals who plan to attend are 

encouraged to register online at the NTP 

Web site (http://ntp.niehs.nih.gov/go/ 

7441) by June 10, 2008. In order to 

facilitate planning, persons wishing to 

make an oral presentation are asked to 

notify Dr. Lori White, NTP Executive 

Secretary, via online registration, phone, 

or email by June 10, 2008 (see 

ADDRESSES below). Written comments 

should also be received by June 10 to 

enable review by SACATM and NIEHS/ 

NTP staff before the meeting. 

ADDRESSES: The SACATM meeting will 

be held at the Radisson Hotel Research 

Triangle Park, 150 Park Drive, Research 

Triangle Park, NC 27709 [hotel: (919) 

549–8631]. Public comments and other 

correspondence should be directed to 

Dr. Lori White (NTP Office of Liaison, 

Policy and Review, NIEHS, P.O. Box 

12233, MD A3–01, Research Triangle 

Park, NC 27709; telephone: 919–541–

9834 or e-mail: whiteld@niehs.nih.gov). 

Courier address: NIEHS, 111 T.W. 

Alexander Drive, Room A326, Research 

Triangle Park, NC 27709. Persons 

needing interpreting services in order to 

attend should contact 301–402–8180 

(voice) or 301–435–1908 (TTY). 

Requests should be made at least 7 days 

in advance of the meeting. 

SUPPLEMENTARY INFORMATION: 

Preliminary Agenda Topics and 

Availability of Meeting Materials 

Preliminary agenda topics include: 

• NICEATM–ICCVAM Update; 

• Overview of NICEATM–ICCVAM 

5–Year Plan; 

• NRC Report: Toxicity Testing in the 

21st Century; 

• Presentations from Federal 

Agencies on Research, Development, 

Translation, and Validation Activities 

Relevant to the NICEATM–ICCVAM 

Five-Year Plan; 

• Report on the ICCVAM–NICEATM 

Independent Scientific Peer Review 

Meeting: Validation Status of New 

Versions and Applications of the 

Murine Local Lymph Node Assay 

(LLNA), a Test Method for Assessing the 

Contact Dermatitis Potential of 

Chemicals and Products; 

• Report on the ICCVAM–NICEATM–

ECVAM–JACVAM Scientific Workshop 

on Acute Chemical Safety Testing: 

Advancing In Vitro Approaches and 

Humane Endpoints for Systemic 

Toxicity Evaluations; 

• Nominations to ICCVAM: NTP 

Rodent Bioassay for Carcinogenicity; 

• Proposal for International 

Cooperation on Alternative Test 

Methods; 

• Update from the Japanese Center for 

the Validation of Alternative Methods; 

• Update from the European Center 

for the Evaluation of Alternative 

Methods, 

A copy of the preliminary agenda, 

committee roster, and additional 

information, when available will be 

posted on the NTP Web site (http:// 

ntp.niehs.nih.gov/go/7441) or available 

upon request (see ADDRESSES above). 

Following the SACATM meeting, 

summary minutes will be prepared and 

available on the NTP website or upon 

request. 

Request for Comments 

Both written and oral public input on 

the agenda topics is invited. Written 

comments received in response to this 

notice will be posted on the NTP Web 

site. Persons submitting written 

comments should include their name, 

affiliation (if applicable), and 

sponsoring organization (if any) with 

the document. Time is allotted during 

the meeting for presentation of oral 

comments and each organization is 

allowed one time slot per public 

comment period. At least 7 minutes will 

be allotted for each speaker, and if time 

permits, may be extended up to 10 

minutes at the discretion of the chair. 

Registration for oral comments will also 

be available on-site, although time 

allowed for presentation by on-site 

registrants may be less than for preregistered speakers and will be 

determined by the number of persons 

who register at the meeting. 

Persons registering to make oral 

comments are asked to do so through 

the online registration form (http:// 

ntp.niehs.nih.gov/go/7441) and to send 

a copy of their statement to Dr. White 

(see ADDRESSES above) by June 10 to 

enable review by SACATM, NICEATM–

ICCVAM, and NIEHS/NTP staff prior to 

the meeting. Written statements can 

supplement and may expand the oral 

presentation. If registering on-site and 

reading from written text, please bring 

40 copies of the statement for 

distribution and to supplement the 

record. 

Background Information on ICCVAM, 

NICEATM, and SACATM 

ICCVAM is an interagency committee 

composed of representatives from 15 

Federal regulatory and research agencies 

that use, generate, or disseminate 

toxicological information. ICCVAM 

conducts technical evaluations of new, 

revised, and alternative methods with 

regulatory applicability and promotes 

the development, scientific validation, 

regulatory acceptance, implementation, 

and national and international 

harmonization of new, revised, and 

alternative toxicological test methods 

that more accurately assess the safety 

and hazards of chemicals and products 

and that refine, reduce, and replace 

animal use. The ICCVAM Authorization 

Act of 2000 [42 U.S.C. 285l–3] 

established ICCVAM as a permanent 

interagency committee of the NIEHS 

under NICEATM. NICEATM 

administers ICCVAM and provides 

scientific and operational support for 

ICCVAM-related activities. NICEATM 

and ICCVAM work collaboratively to 

evaluate new and improved test 

methods applicable to the needs of U.S. 

Federal agencies. Additional 

information about ICCVAM and 

NICEATM can be found on their Web 

site (http://iccvam.niehs.nih.gov). 

SACATM was established in response 

to the ICCVAM Authorization Act 

[Section 285l–3(d)] and is composed of 

scientists from the public and private 

sectors. SACATM advises ICCVAM, 

NICEATM, and the Director of the 

NIEHS and NTP regarding statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. SACATM 

provides advice on priorities and 

activities related to the development, 

validation, scientific review, regulatory 

acceptance, implementation, and 

national and international 

harmonization of new, revised, and 

alternative toxicological test methods. 

Additional information about SACATM, 

including the charter, roster, and 

records of past meetings, can be found 

at http://ntp.niehs.nih.gov/go/167. 

Dated: April 28, 2008. 

Samuel H. Wilson, 

Acting Director, National Institute of 

Environmental Health Sciences and National 

Toxicology Program. 

[FR Doc. E8–10010 Filed 5–6–08; 8:45 am] 

BILLING CODE 4140–01–P 


sroberts on PROD1PC70 with NOTICES